Patent · US Active

Detection and quantitation of full-length thioredoxin (TRX) and truncated thioredoxin (TRX 80) in complex samples

US8512963B2 · kind B2 · utility

4Cited by

0References

14Claims

0Family size

Assignee

THE JOHNS HOPKINS UNIVERSITY · US

Inventors

David Graham · Baltimore, US
Susan Christine Trow · Baltimore, US
Mary Christine Zink · Baltimore, US

Key dates

Filing date	Nov 23, 2010
Grant date	Aug 20, 2013
Priority date	—
Expiry date	Mar 23, 2031

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/6851
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates, e.g., to a method for detecting a full-length protein and a truncated form (e.g., a naturally occurring cleavage product) thereof, in a sample, comprising In one embodiment of the invention, the full-length protein is thioredoxin (TRX), and the truncated form thereof is its biologically active, C-terminal truncated, 10 kDa cleavage product, TRX 80.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.